J. Wright
Journal of the American Medical Association (JAMA) · 2002–2019
A researcher in the Science corpus: 18 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Whom J. Wright trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Wright overall
Papers from J. Wright's perspective
Ordered by how strongly the researchers J. Wright trusts endorse each paper. Same corpus, a different order for every researcher.
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
- Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (New England Journal of Medicine)
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
- Prevalence and trends in obesity among US adults, 1999-2000. (Journal of the American Medical Association (JAMA))
- Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. (Journal of the American Medical Association (JAMA))
- Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. (New England Journal of Medicine)
- Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. (Diabetes Care)
- Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional… (HYPERTENSION)
- Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. (New England Journal of Medicine)
Their papers
- Measurement of Blood Pressure in Humans (2019) — 1,063 citations
- Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia (2019) — 1,034 citations
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) — 1,758 citations
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) — 2,737 citations
- Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline (2017) — 748 citations
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control. (2016) — 1,164 citations
- Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. (2016) — 1,186 citations
- 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). (2014) — 7,920 citations
- APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease (2013) — 721 citations
- Association of estimated glomerular filtration rate and albuminuria with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease cohorts (2011) — 750 citations
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease (2010) — 688 citations
- Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. (2004) — 781 citations
- The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. (2003) — 595 citations
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (2003) — 26,011 citations
- Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (2003) — 15,938 citations
- Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). (2002) — 1,306 citations
- Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. (2002) — 2,073 citations
- Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2002) — 5,360 citations